Table 2 Seven-day mortality risk analysis among CRE cases with pathogen surveillance data (N = 740)

Male

1.72 (0.79–3.75)

0.202

–

–

Age < 18 years

1.92 (0.43–8.51)

0.308

–

–

Age > 64 years

2.43 (0.73–8.06)

0.174

–

–

Urinary tract infection

0.44 (0.18–1.08)

0.087

–

–

Bloodstream infection

2.87 (1.42–5.8)

0.005

4.00 (1.88–8.52)

0.0003

Respiratory tract infection

2.94 (1.45–5.97)

0.005

4.71 (2.17–10.24)

< 0.0001

Intra-abdominal infection

1.3 (0.62–2.74)

0.552

–

–

Bone and soft tissue infection

0.71 (0.17–3.03)

1.000

–

–

Escherichia coli

4.12 (1.83–9.27)

0.002

5.17 (2.18–12.24)

0.0002

Klebsiella aerogenes

0.65 (0.29–1.47)

0.346

–

–

Klebsiella pneumoniae

0.75 (0.22–2.52)

1.000

–

–

Enterobacter cloacae complex

0.85 (0.38–1.91)

0.842

–

–

Serratia marcescens

2.62 (0.75–9.14)

0.134

–

–

Carbapenemase gene-positive Enterobacterales

1.62 (0.78–3.37)

0.225

–

–